About N-[2-(3-oxo-6,7-dihydro-5H-cyclopenta[c]pyridazin-2-yl)ethyl]-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide
N-[2-(3-oxo-6,7-dihydro-5H-cyclopenta[c]pyridazin-2-yl)ethyl]-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide (PubChem CID 122280758) has the molecular formula C14H18N4O4
and a molecular weight of 306.32 g/mol. Its IUPAC name is N-[2-(3-oxo-6,7-dihydro-5H-cyclopenta[c]pyridazin-2-yl)ethyl]-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide.
Molecular Properties
| Compound Name | N-[2-(3-oxo-6,7-dihydro-5H-cyclopenta[c]pyridazin-2-yl)ethyl]-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide |
| PubChem CID | 122280758 |
| Molecular Formula | C14H18N4O4 |
| Molecular Weight | 306.32 g/mol |
| Exact Mass | 306.13 |
| IUPAC Name | N-[2-(3-oxo-6,7-dihydro-5H-cyclopenta[c]pyridazin-2-yl)ethyl]-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide |
| SMILES | O=C(CN1CCOC1=O)NCCn1nc2c(cc1=O)CCC2 |
| InChI | InChI=1S/C14H18N4O4/c19-12(9-17-6-7-22-14(17)21)15-4-5-18-13(20)8-10-2-1-3-11(10)16-18/h8H,1-7,9H2,(H,15,19) |
| InChIKey | IBFYJXZDCAWQOR-UHFFFAOYSA-N |
| XLogP | -0.70 |
| TPSA | 93.53 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 22 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
| MW ≤ 500 | 306.32 |
| LogP ≤ 5 | -0.70 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Analyze N-[2-(3-oxo-6,7-dihydro-5H-cyclopenta[c]pyridazin-2-yl)ethyl]-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-[2-(3-oxo-6,7-dihydro-5H-cyclopenta[c]pyridazin-2-yl)ethyl]-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide?
The IUPAC name of N-[2-(3-oxo-6,7-dihydro-5H-cyclopenta[c]pyridazin-2-yl)ethyl]-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide (CID 122280758) is N-[2-(3-oxo-6,7-dihydro-5H-cyclopenta[c]pyridazin-2-yl)ethyl]-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide.
What is the SMILES notation for N-[2-(3-oxo-6,7-dihydro-5H-cyclopenta[c]pyridazin-2-yl)ethyl]-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide?
The canonical SMILES for N-[2-(3-oxo-6,7-dihydro-5H-cyclopenta[c]pyridazin-2-yl)ethyl]-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide is O=C(CN1CCOC1=O)NCCn1nc2c(cc1=O)CCC2.
What is the InChIKey of N-[2-(3-oxo-6,7-dihydro-5H-cyclopenta[c]pyridazin-2-yl)ethyl]-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide?
The InChIKey is IBFYJXZDCAWQOR-UHFFFAOYSA-N. The full InChI is InChI=1S/C14H18N4O4/c19-12(9-17-6-7-22-14(17)21)15-4-5-18-13(20)8-10-2-1-3-11(10)16-18/h8H,1-7,9H2,(H,15,19).
What are the key properties of N-[2-(3-oxo-6,7-dihydro-5H-cyclopenta[c]pyridazin-2-yl)ethyl]-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide?
N-[2-(3-oxo-6,7-dihydro-5H-cyclopenta[c]pyridazin-2-yl)ethyl]-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide has a molecular weight of 306.32 g/mol, XLogP of -0.70, 5 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-(3-oxo-6,7-dihydro-5H-cyclopenta[c]pyridazin-2-yl)ethyl]-2-(2-oxo-1,3-oxazolidin-3-yl)acetamide is sourced from PubChem (CID 122280758), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).